Stay updated on Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedChanges are limited to site revision updates (Revision: v3.4.2) and removal of a prior funding/operating-status notice; there are no changes to study details, eligibility, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA government funding lapse notice was added, warning that information may not be up to date and transactions may be delayed. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedMinor UI text updates on the study page include showing the glossary toggle and small wording/capitalization changes to QC-related labels and revision/version text; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 appears in the page footer, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedBeijing Municipality was added as a study location under the Locations section, and the Beijing Municipality Locations entry plus the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedFooter revision note updated from Revision: v3.3.1 to Revision: v3.3.2. No changes to the study details or other user-facing content.SummaryDifference0.1%

Stay in the know with updates to Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.